The data disclosed a correlation between the overexpression of FGR and reduced overall survival (OS) with a hazard ratio (HR) of 1.36 (95% CI: 1.08 – 1.7, log-rank P = 0.0078) and DFS with an HR of 1.59 (95% CI: 1.13–2.23, log-rank P = 0.0072) in CRC patients. This evidence concerns the gene FGR and colorectal carcinoma.